Pfizer EBIT 2010-2024 | PFE

Pfizer EBIT for the quarter ending December 31, 2024 was $2.348B, a 143.93% decline year-over-year.

  • Pfizer 2024 EBIT was 12.411B, a 5490.54% increase from 2023.
  • Pfizer 2023 EBIT was 0.222B, a 99.36% decline from 2022.
  • Pfizer 2022 EBIT was 34.944B, a 79.82% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Pfizer EBIT 2010-2024 | PFE

  • Pfizer 2024 EBIT was 12.411B, a 5490.54% increase from 2023.
  • Pfizer 2023 EBIT was 0.222B, a 99.36% decline from 2022.
  • Pfizer 2022 EBIT was 34.944B, a 79.82% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B